Matthew L. Crawley

3.7k total citations · 1 hit paper
17 papers, 3.0k citations indexed

About

Matthew L. Crawley is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Matthew L. Crawley has authored 17 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Organic Chemistry, 8 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Matthew L. Crawley's work include Asymmetric Synthesis and Catalysis (6 papers), Chemical Synthesis and Analysis (4 papers) and Protein Tyrosine Phosphatases (4 papers). Matthew L. Crawley is often cited by papers focused on Asymmetric Synthesis and Catalysis (6 papers), Chemical Synthesis and Analysis (4 papers) and Protein Tyrosine Phosphatases (4 papers). Matthew L. Crawley collaborates with scholars based in United States. Matthew L. Crawley's co-authors include Barry M. Trost, Chul Bom Lee, John F. Mehlmann, Paige E. Mahaney, Andrew P. Combs, Erin McLaughlin, Igor Goljer, Timothy C. Burn, Lucie Gonneville and Richard Wynn and has published in prestigious journals such as Chemical Reviews, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Matthew L. Crawley

17 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Asymmetric Transition-Metal-Catalyzed Allylic Alkylations: Applications in Total Synthesis

2003 2.5k citations Barry M. Trost, Matthew L. Crawley Chemical Reviews profile →

Peers

Countries citing papers authored by Matthew L. Crawley

Since Specialization

Citations

This map shows the geographic impact of Matthew L. Crawley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew L. Crawley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew L. Crawley more than expected).

Fields of papers citing papers by Matthew L. Crawley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew L. Crawley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew L. Crawley. The network helps show where Matthew L. Crawley may publish in the future.

Co-authorship network of co-authors of Matthew L. Crawley

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew L. Crawley. A scholar is included among the top collaborators of Matthew L. Crawley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew L. Crawley. Matthew L. Crawley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Farnesoid X receptor modulators: a patent review 2010 ·Expert Opinion on Therapeutic Patents ·Matthew L. Crawley	21
2	Improvement of Physiochemical Properties of the Tetrahydroazepinoindole Series of Farnesoid X Receptor (FXR) Agonists: Beneficial Modulation of Lipids in Primates 2010 ·Journal of Medicinal Chemistry ·Joseph T. Lundquist, Douglas C. Harnish, (unknown), John F. Mehlmann, Rayomand J. Unwalla, (unknown), Matthew L. Crawley, (unknown), Daniel M. Green, Weixin Xu, Wah-Tung Hum, (unknown), Irene Feingold, (unknown), Mark J. Evans, KehDih Lai, Lisa Borges-Marcucci, Paige E. Mahaney, Jay Wrobel	42
3	Pyrrole[2,3-d]azepino compounds as agonists of the farnesoid X receptor (FXR) 2009 ·Bioorganic & Medicinal Chemistry Letters ·John F. Mehlmann, Matthew L. Crawley, Joseph T. Lundquist, Ray Unwalla, Douglas C. Harnish, Mark J. Evans, (unknown), Jay Wrobel, Paige E. Mahaney	19
4	Efficient, Regioselective Palladium-Catalyzed Tandem Heck-Isomerization Reaction of Aryl Bromides and Non-Allylic Benzyl Alcohols 2009 ·Organic Letters ·Matthew L. Crawley, (unknown), Igor Goljer, John F. Mehlmann, Joseph T. Lundquist, (unknown), (unknown), Paige E. Mahaney	19
5	Structural Insights into the Design of Nonpeptidic Isothiazolidinone-containing Inhibitors of Protein-tyrosine Phosphatase 1B 2006 ·Journal of Biological Chemistry ·J. Paul, Lucie Gonneville, Milton C. Hillman, (unknown), Eddy W. Yue, Brent Douty, Brian Wayland, Padmaja Polam, Matthew L. Crawley, Erin McLaughlin, Richard Sparks, Brian Glass, Amy Takvorian, Andrew P. Combs, Timothy C. Burn, Gregory Hollis, Richard Wynn	55
6	S,O‐Acetals as Novel “Chiral Aldehyde” Equivalents 2006 ·Chemistry - A European Journal ·Barry M. Trost, Matthew L. Crawley, Chul Bom Lee	20
7	Isothiazolidinone heterocycles as inhibitors of protein tyrosine phosphatases: Synthesis and structure–activity relationships of a peptide scaffold 2006 ·Bioorganic & Medicinal Chemistry ·Eddy W. Yue, Brian Wayland, Brent Douty, Matthew L. Crawley, Erin McLaughlin, Amy Takvorian, Zelda R. Wasserman, Michael J. Bower, Min Wei, Yanlong Li, J. Paul, Lucie Gonneville, Richard Wynn, Timothy C. Burn, Phillip C.C. Liu, Andrew P. Combs	44
8	Benzothiazole benzimidazole (S)-isothiazolidinone derivatives as protein tyrosine phosphatase-1B inhibitors 2006 ·Bioorganic & Medicinal Chemistry Letters ·Richard Sparks, Padmaja Polam, Wenyu Zhu, Matthew L. Crawley, Amy Takvorian, Erin McLaughlin, Min Wei, J. Paul, Lucie Gonneville, Nancy J. Taylor, Yanlong Li, Richard Wynn, Timothy C. Burn, Phillip C.C. Liu, Andrew P. Combs	49
9	Regioselective Synthesis of Substituted Pyrroles: Efficient Palladium-Catalyzed Cyclization of Internal Alkynes and 2-Amino-3-iodoacrylate Derivatives 2006 ·Organic Letters ·Matthew L. Crawley, Igor Goljer, (unknown), John F. Mehlmann, Lisa Nogle, (unknown), Paige E. Mahaney	62
10	Concise Approach to Novel Isothiazolidinone Phosphotyrosine Mimetics: Microwave-Assisted Addition of Bisulfite to Activated Olefins 2005 ·Organic Letters ·Matthew L. Crawley, Erin McLaughlin, Wenyu Zhu, Andrew P. Combs	10
11	A “Chiral Aldehyde” Equivalent as a Building Block Towards Biologically Active Targets 2004 ·Chemistry - A European Journal ·Barry M. Trost, Matthew L. Crawley	58
12	Efficient Synthesis of 4,4-Dimethyl-1,9,10(1H)-Anthracenetrione 2003 ·Journal of Chemical Research ·Matthew L. Crawley, (unknown), J. Hodge Markgraf	4
13	Asymmetric Transition‐Metal‐Catalyzed Allylic Alkylations: Applications in Total Synthesis 2003 ·ChemInform ·Barry M. Trost, Matthew L. Crawley	1
14	Asymmetric Transition-Metal-Catalyzed Allylic Alkylations: Applications in Total Synthesis breakdown → 2003 ·Chemical Reviews ·Barry M. Trost, Matthew L. Crawley	2501
15	4-Aryloxybutenolides As “Chiral Aldehyde” Equivalents: An Efficient Enantioselective Synthesis of (+)-Brefeldin A 2002 ·Journal of the American Chemical Society ·Barry M. Trost, Matthew L. Crawley	86
16	α-Acetoxysulfones as “Chiral Aldehyde” Equivalents 2000 ·Journal of the American Chemical Society ·Barry M. Trost, Matthew L. Crawley, Chul Bom Lee	54
17	SYNTHESIS OF BENZO[c][2,7]NAPHTHYRIDINES AND 2,13-DIAZABENZO[b]CHRYSENE 1998 ·Organic Preparations and Procedures International ·Charles F. Nutaitis, Matthew L. Crawley, (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact